This article is based on Mayo Clinic’s content.

What is osteoporosis?

Osteoporosis causes the bones to weaken, so that a fall or even a slight tension, such as bending or coughing, can cause a fracture. Fractures related to osteoporosis usually occur in the hips, wrists and spine.

Bones are living tissues that are broken down and replaced constantly. Osteoporosis occurs when the generation of new bone tissue is slower than the removal of old bone tissue and the bone becomes weakened in structure.

Osteoporosis affects men and women of all races. However, white and Asian women (particularly older and post-menopausal women) are more at risk. Certain medications, a healthy diet, and exercises that include lifting weights or resistance training, can help prevent bone loss and strengthen weak bones.

Do you want to know more about osteoporosis?

We recommend that you continue reading the Disease and Conditions page of the Mayo Clinic for the public.

What mushrooms have useful properties in osteoporosis?


It favors the creation of new bone cells There are studies in which extracts of Reishi promote the formation of new bone cells, a powerful agent in combating this disease.


The Cordyceps, in addition to acting as a regulator at the endocrine (hormone) level, acts on the energy metabolism, so it is an ideal complement at the level of both physical and mental fatigue.


  1. Zhang DW, Wang ZL, Qi W, Zhao GY. The effects of Cordyceps sinensis phytoestrogen on estrogen deficiency-induced osteoporosis in ovariectomized rats. BMC Complement Altern Med. 2014 Dec 13;14:484. doi: 10.1186/1472-6882-14-484.
  2. Qi W, Wang PJ, Guo WJ, Yan YB, Zhang Y, Lei W. The mechanism of Cordyceps sinensis and strontium in prevention of osteoporosis in rats. Biol Trace Elem Res. 2011 Oct;143(1):302-9. doi: 10.1007/s12011-010-8829-4.
  3. Qi W, Yan YB, Wang PJ, Lei W. The co-effect of Cordyceps sinensis and strontium on osteoporosis in ovariectomized osteopenic rats. Biol Trace Elem Res. 2011 Jun;141(1-3):216-23. doi: 10.1007/s12011-010-8711-4. Epub 2010 May 5.
  4. Liu J, Shiono J, Shimizu K, Kondo R. Ganoderic acids from Ganoderma lucidum: inhibitory activity of osteoclastic differentiation and structural criteria. Planta Med. 2010 Feb;76(2):137-9. doi: 10.1055/s-0029-1186035. Epub 2009 Aug 10.
  5. Miyamoto I, Liu J, Shimizu K, Sato M, Kukita A, Kukita T, Kondo R. Regulation of osteoclastogenesis by ganoderic acid DM isolated from Ganoderma lucidum. Eur J Pharmacol. 2009 Jan 5;602(1):1-7. doi: 10.1016/j.ejphar.2008.11.005. Epub 2008 Nov 9. PubMed PMID: 19026632.